Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,107 | -4,842 | -3,985 | -2,962 | N/A |
| Depreciation Amortization | 508 | 52 | 30 | 15 | N/A |
| Other Working Capital | -246 | 634 | 98 | 1,422 | N/A |
| Other Operating Activity | 945 | 323 | 423 | 208 | 0 |
| Operating Cash Flow | $-8,900 | $-3,834 | $-3,434 | $-1,317 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | N/A | -20 | N/A | N/A |
| Investing Cash Flow | $-37 | $0 | $-20 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,068 | 4,903 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 0 | 2,581 | N/A | N/A |
| Dividend Paid | N/A | N/A | -4 | -2 | N/A |
| Other Financing Activity | -1,485 | -272 | 0 | 0 | 0 |
| Financing Cash Flow | $17,583 | $4,631 | $2,577 | $-2 | $N/A |
| Beginning Cash Position | 3,665 | 3,665 | 1,535 | 1,535 | N/A |
| End Cash Position | 12,311 | 4,462 | 658 | 216 | N/A |
| Net Cash Flow | $8,646 | $797 | $-877 | $-1,319 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,900 | -3,834 | -3,434 | -1,317 | N/A |
| Capital Expenditure | -37 | 0 | -20 | N/A | N/A |
| Free Cash Flow | -8,937 | -3,834 | -3,454 | -1,317 | 0 |